Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study

Home-Time After Discharge Among Patients Hospitalized With Heart Failure

(2018) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outpatient Worsening Heart Failure as a Target for Therapy

(2018) Stephen J. Greene et al.   JAMA Cardiology

Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study

(2017) W. Ouwerkerk et al.   EUROPEAN HEART JOURNAL

Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure

(2017) Adriaan A. Voors et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF

(2017) João Pedro Ferreira et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

(2017) Ovidiu Chioncel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure

(2017) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction

(2017) Scott D. Solomon et al.   JACC-Heart Failure

Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives

(2016) João Pedro Ferreira et al.   BMC Medicine

Importance of Clinical Worsening of Heart Failure Treated in the Outpatient SettingCLINICAL PERSPECTIVE

(2016) Naoki Okumura et al.   CIRCULATION

Geographic variations in the PARADIGM-HF heart failure trial

(2016) Søren Lund Kristensen et al.   EUROPEAN HEART JOURNAL

Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients

(2016) Nuria Farré et al.   EUROPEAN JOURNAL OF HEART FAILURE

A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF

(2016) Adriaan A. Voors et al.   EUROPEAN JOURNAL OF HEART FAILURE

The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database

(2016) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study

(2016) Morten Schmidt et al.   EUROPEAN JOURNAL OF HEART FAILURE

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

(2016) Maria G. Crespo-Leiro et al.   EUROPEAN JOURNAL OF HEART FAILURE

The Primary Outcome Is Positive — Is That Good Enough?

(2016) Stuart J. Pocock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT

(2014) Hicham Skali et al.   EUROPEAN JOURNAL OF HEART FAILURE

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

(2013) Timothy J. Collier et al.   EUROPEAN HEART JOURNAL

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

(2013) Mihai Gheorghiade et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

(2012) John R Teerlink et al.   LANCET

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE